Interesting post, pointing to an interesting paper published last week in the Annals of Emergency Medicine. Excerpt of the post:
Over 14 years, 84 editors at the journal rated close to 15,000 reviews by about 1,500 reviewers. Highlights of their findings:
…92% of peer reviewers deteriorated during 14 years of study in the quality and usefulness of their reviews (as judged by editors at the time of decision), at rates unrelated to the length of their service (but moderately correlated with their mean quality score, with better-than average reviewers decreasing at about half the rate of those below average). Only 8% improved, and those by very small amount.
How bad did they get? The reviewers were rated on a scale of 1 to 5 in which a change of 0.5 (10%) had been earlier shown to be “clinically” important to an editor.
The average reviewer in our study would have taken 12.5 years to reach this threshold; only 3% of reviewers whose quality decreased would have reached it in less than 5 years, and even the worst would take 3.2 years. Another 35% of all reviewers would reach the threshold in 5 to 10 years, 28% in 10 to 15 years, 12% in 15 to 20 years, and 22% in 20 years or more.
So the decline was slow. Still, the results, note the authors, were surprising:
Such a negative overall trend is contrary to most editors’ and reviewers’ intuitive expectations and beliefs about reviewer skills and the benefits of experience.
Journalists should realize the flaws in the peer review system and perhaps reconsider a steady news diet that comes only or mostly from journal articles. And/or be prepared to discuss limitations more often.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Dan Cherkin
November 29, 2010 at 9:29 amI have also noted that the quality of reviews, especially of NIH grant proposals, have deteriorated over the past decade. I wonder if this reflects greater difficulty in obtaining competent reviewers who are no longer willing to review because they have become overburdened responding to incompetent reviews (especially of grant proposals). Also, I believe that many reviewers, both competent and incompetent, are in a chronic state of over-commitment and are reducing the time they spend on lower priorities that have miniminal personal consequences for doing a poor job (e.g., reviewing manuscripts or grant proposals). Many such reviewers would be delighted if editors stopped sending them manuscripts to review!
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like